ONCInformation Blocking

Information Blocking Rule Overview (45 CFR Part 171)

The 21st Century Cures Act information blocking provisions and the ONC rule prohibiting actions by providers, health IT developers, and HINs/HIEs that interfere with electronic health information access, exchange, or use.

Primary source

45 CFR Part 171 — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-D/part-171

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR Part 171 — the Information Blocking Rule promulgated by ONC under the 21st Century Cures Act — prohibits practices likely to interfere with the access, exchange, or use of electronic health information (EHI) by health care providers, health IT developers of certified technology, and health information networks/exchanges (HINs/HIEs).

A practice is information blocking if it is:

EHI scope expanded from the USCDI subset to the full Designated Record Set definition on October 6, 2022.

Eight regulatory exceptions at 45 CFR 171.200-303 carve out practices that are not information blocking when each exception's conditions are met. Outside an exception, the activity may be information blocking and subject to enforcement.

Enforcement: HHS OIG investigates and may impose CMPs up to $1M per violation against developers and HINs/HIEs. For providers, CMS imposes "disincentives" — payment reductions and program-eligibility consequences — under separate authority finalized in 2024.

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.